/Investor DB

Braven

Venture capital

New York · Seed–Series A · 17 people tracked

Find your way into Braven

Sign up to see every warm intro you have to Braven

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Braven team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

✨ Fox Verdict
Sign up to see your fit

Investment thesis

Braven pursues opportunities with meaningful societal impact and strong financial returns by cobuilding companies in highly regulated sectors such as financial services, insurance, and healthcare & life sciences. The firm applies a disciplined due diligence approach and pairs portfolio companies with specialized teams of operators ('Braveneers') and advisors who augment company capabilities, unlock value, and accelerate success. It emphasizes governance, risk management, and the application of AI and advanced analytics across its focus industries.

Source: firm website, verified Oct 26, 2026.

Stage
Seed–Series A
HQ
New York, New York, US
Instruments
Equity
Founded
2022

Team · 17 people

from the firm's website & public directories
William Abecassis· Managing Partner and Chief Investment Officerin

Founder of Braven and former lead of BlackRock's $1B+ Innovation Capital venture group; previously held investment and technical roles at Bridgewater Associates and founded consulting firm LogisticScience.

Joel Herold· Cobuild Partner, Financial Services & Insurancein

Former Chief Legal Officer at DRI Capital and Reservoir Media and a partner at Cravath, Swaine & Moore with deep experience in M&A, capital markets, and structured finance across regulated industries.

LizAnn Eisen· Senior Partner, Regulatory & Strategyin

Former SEC Deputy Director of Disclosure Operations in the Division of Corporation Finance and a longtime partner at Cravath, Swaine & Moore; also teaches at Cornell and University of Oregon law schools.

Bradford Wilkins· Senior Partner, Talent & Performancein

HR and talent leader who was Chief People Officer at Loadsmart, VP of People at Collibra, and Chief People Officer at Altisource, building modern HR practices at high-growth companies.

Adam King· Intern, Financial Services & Insurancein

Finance student and intern with prior venture experience at Battery Ventures and EPIC Ventures, supporting Braven's research on market opportunities and companies.

Bill Priestap· Advisory Board, Cyber Intelligence, Risk Management, National Securityin

Former FBI head of Counterintelligence and co-founder of Trenchcoat Advisors, advising companies and investment firms on intelligence, risk, and national security threats.

Deborah Chase Hopkins· Advisory Board, Financial & Insurance Innovation, Cyber, Industrials, Venture

Founder and former CEO of Citi Ventures and Citi's first Chief Innovation Officer, previously CFO at Boeing and Lucent, and a board member at Marsh & McLennan and Union Pacific.

Eddie Lei· Fellow, Financial Services & Insurancein

First Chief Innovation Officer at CV Starr and former director at JenCap Holdings and partner at consulting group FinMirai, focused on insurance innovation.

Irving Wladawsky-Berger· Advisory Board, Machine Intelligence, Technical & Innovation Strategy

IBM veteran of 37 years who led initiatives including the Internet, supercomputing, and Linux, and is a research affiliate at MIT Sloan with advisory roles in digital strategy.

Jay Krzyston· Fellow, Computing & Technologyin

AI researcher who completed a PhD at Georgia Tech while working as an AI Research Engineer at the Georgia Tech Research Institute, with published award-winning AI research.

Jeremy Chizewer· Fellow, Computing & Technologyin

Mathematics graduate student at the University of Waterloo and Princeton computer science graduate whose combinatorics research was published in Discrete Mathematics; previously a software engineer at RestAR.

Jon Terenzetti· Fellow, Healthcare & Life Sciencesin

Strategy and operations leader who was a principal at Haven Healthcare and VP of Strategy & Data Transformation at CareCentrix, focused on healthcare value creation.

Kiran Yemul· Fellow, Healthcare & Life Sciencesin

Former Financial Strategy Director at Sg2 serving health systems and life science clients, with experience in medical device startups and value-based care.

Margaret Berno· Operations Associatein

Former senior associate consultant at Bain & Company with experience in operating model design and revenue acceleration, and prior work with social enterprise Sanergy in Nairobi.

Philip Gelston· Advisory Board, Regulatory, Insurance & Industrial Transactions

Director of White Mountains Insurance Group and retired Cravath, Swaine & Moore partner with extensive M&A and corporate governance experience.

Prithvi Addepalli· Fellow, Healthcare & Life Sciencesin

Life sciences professional who was a consulting manager at IQVIA and a senior product manager for Health and Life Sciences at Microsoft + Nuance, focused on AI/ML initiatives.

Ross Levinsky· Advisory Board, Trading Technology, Financial Platforms

Chief Technology Officer and Managing Director at HBK, former Managing Director at Goldman Sachs, with prior technical roles at Google, Bridgewater, and D.E. Shaw.

Frequently asked questions

What stage does Braven invest at?
Braven invests at the Seed, Series A stages.
What sectors does Braven focus on?
Braven focuses on Advanced Manufacturing, AI & Machine Learning, Biotech, Cybersecurity, Digital Health, Fintech, Healthtech, InsurTech.
Where is Braven located?
Braven is headquartered in New York, US.

Images

Braven photo

Similar investors

Featured in lists